All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 08d06-77 that has a similar product distributed in the us, list number 08d06-31/-41.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, in house testing of a retained reagent kit, and return specimen testing.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The ticket search by lot indicates that the complaint lot performs as expected for this product.Ticket trending review did not identify any trends regarding commonalities for complaint lot.Device history review did not identify any non-conformances or deviations with the complaint lot.The returned specimen was tested with the following results: sample id (b)(6).Architect syphilis tp: 0.46 s/co (non-reactive).Recomline treponema igm: negative.Recomline treponema igg: negative.During in-house testing a non-reactive result was generated for the return sample with lot 50319be01.No discrepant results were obtained.In-house testing of lot 52310be00, lot number contains the same bulk material as lot number 52310be01, was completed using panels which mimic patient samples using an in-house retained kit.All specifications were met indicating the lot is performing acceptably.Labeling was reviewed and sufficiently addresses the customer¿s issue.Based on the investigation, no systemic issue or deficiency of the architect syphilis tp reagent lot 52310be01 was identified.
|